| Chronic complement dysregulation drives neuroinflammation after traumatic brain injury: a transcriptomic study A Toutonji, M Mandava, S Guglietta, S Tomlinson Acta Neuropathologica Communications 9, 1-18, 2021 | 24 | 2021 |
| Maxillofacial extramedullary hematopoiesis in a child with sickle cell presenting as bilateral periorbital cellulitis DA Reiersen, M Mandava, M Jeroudi, A Gungor International Journal of Pediatric Otorhinolaryngology 78 (7), 1173-1175, 2014 | 7 | 2014 |
| A rare case of stroke in an adolescent violinist due to thoracic outlet syndrome S Kuril, PR Chopade, M Mandava, S Bhatia Neurology India 69 (6), 1777-1780, 2021 | 3 | 2021 |
| Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease H Kinoshita, M Mandava, M Jensen-Wachspress, H Lang, E Joy, J Tanna, ... Blood advances 7 (10), 2105-2116, 2023 | 2 | 2023 |
| 391-Clinical Outcomes and Long-Term Follow-up of Children with Mixed Myeloid Chimerism Following Hematopoietic Cell Transplantation (HCT) for Sickle Cell Disease (SCD) GMT Guilcher, S Dalal, T Suresh, AR Yelamali, H Aljayyousi, M Bhatia, ... Transplantation and cellular therapy 29 (2), S296-S297, 2023 | 2 | 2023 |
| Sickle cell disease related outcomes in patients evaluated for COVID-19 infections in south carolina L Noisette, M Mandava, M Gregoski, S Bergmann Blood 136, 38-39, 2020 | 2 | 2020 |
| A Unique Case of Type 3 Von Willebrand Disease M Mandava, J Lazarchick, E Curl, S Bergmann Blood 132, 5031, 2018 | 2 | 2018 |
| A27: polyomavirus excretion in children with rheumatic diseases on immunosuppressive therapy V Raman, M Hollister, S Umer, S Habib, M Mandava, G McClure, ... Arthritis & Rheumatology 66, S42-S42, 2014 | 2 | 2014 |
| Thyroid and adrenal dysfunction in Hemoglobinopathies before and after allogeneic hematopoietic cell transplant M Mandava, J Lew, JF Tisdale, E Limerick, CD Fitzhugh, MM Hsieh Journal of the Endocrine Society 7 (12), bvad134, 2023 | 1 | 2023 |
| Mass cytometric analysis of the immune cell landscape after traumatic brain injury elucidates the role of complement and complement receptors in neurologic outcomes A Toutonji, C Krieg, DM Borucki, M Mandava, S Guglietta, S Tomlinson Acta Neuropathologica Communications 11 (1), 92, 2023 | 1 | 2023 |
| P-080: IMPLEMENTATION OF SCREENING TOOL IN SICKLE CELL CLINIC TO IDENTIFY SOCIAL DETERMINANTS OF HEALTH J PATEL, M MANDAVA, L NOISETTE, C DIAZ, A BORAD, S JACKSON, ... HemaSphere 6, 54-55, 2022 | | 2022 |
| The role of complement in propagating neuroinflammation in chronic traumatic brain injury-A transcriptomic analysis A Toutonji, M Mandava, S Guglietta, S Tomlinson MOLECULAR IMMUNOLOGY 141, 228-229, 2022 | | 2022 |
| A Case of Undetectable T-cell Receptor Excision Circle (TREC) and Multiple Congenital Anomalies BP DePriest, M Mandava, M Hudspeth, M Markert, E Haddad, K Williams JOURNAL OF CLINICAL IMMUNOLOGY 41 (SUPPL 1), S94-S94, 2021 | | 2021 |
| Improving Postoperative Pain Following Bone Marrow Harvesting: A Narcotic Sparing, Regional Anesthesia Based Approach. N McCoy, M Hudspeth, E Hay, D Romeo, M Mandava, S Warneke 2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021 | | 2021 |
| Red Blood Cell (RBC) Allo-Immunization Risk Factors and Impact on Outcomes for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Patients M Mandava, D Ogden, M Gregoski, K Martin, AK Neppalli, JJ Jaroscak, ... 2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021 | | 2021 |
| IOBAN: ONE MORE STEP TOWARDS GRAFT CONTAMINATION PREVENTION DURING BONE MARROW HARVEST M Mandava, E Williams, J Jaroscak, M Hudspeth PEDIATRIC BLOOD & CANCER 67, S82-S82, 2020 | | 2020 |
| Pjp Breakthrough Rates in Pediatric Allo-HSCT Patients Receiving a 2 Days per Week Sulfamethoxazole/Trimethoprim (SMX/TMP) Prophylaxis Regimen M Mandava, J Heh, JJ Jaroscak, M Hudspeth Biology of Blood and Marrow Transplantation 26 (3), S338, 2020 | | 2020 |
| Impact of Adenovirus Stool PCR Screening on Incidence, Management, and Outcomes in Pediatric Hematopoietic Stem Cell Transplant Patients (HSCT) M Mandava, A Wahlquist, JJ Jaroscak, M Hudspeth Biology of Blood and Marrow Transplantation 26 (3), S336, 2020 | | 2020 |
| CASE-CONTROL STUDY OF PNEUMOMEDIASTINUM IN PEDIATRIC ALLOGENEIC HSCT PATIENTS M Mandava, A Wahlquist, J Jaroscak, M Hudspeth PEDIATRIC BLOOD & CANCER 66, 2019 | | 2019 |
| A Novel Case of Compound Heterozygous Type 3 Von Willebrand Disease M Mandava, S Bergmann, J Lazarchick Annals of Clinical & Laboratory Science 49 (3), 393-394, 2019 | | 2019 |
